Haematology Oncology Strong — NICE NG143 / Carmona-Bayonas 2015
CISNE Score for Febrile Neutropenia
Clinical Index of Stable Febrile Neutropenia (CISNE) — identifies low-risk solid tumour patients with febrile neutropenia suitable for oral antibiotics and early discharge.
References
- Carmona-Bayonas A et al. Prediction of serious complications in patients with seemingly stable febrile neutropenia: validation of the Clinical Index of Stable Febrile Neutropenia in a prospective cohort of patients from the FINITE study. J Clin Oncol. 2015.
- NICE NG143. Neutropenic sepsis: prevention and management in people with cancer. 2012.
Related
Curated clinical cross-links plus same-class fallbacks.
Calculators
Drugs
- Meropenem (Paediatric) · Carbapenem — Severe / MDR Gram-Negative Infections / Febrile Neutropenia
- Ciprofloxacin Ear Drops · Topical Fluoroquinolone Antibiotic
- Ciprofloxacin · Fluoroquinolone Antibiotic
- Ciprofloxacin · Fluoroquinolone antibiotic
- Ciprofloxacin with dexamethasone · Topical otic antibiotic + corticosteroid
- Ciprofloxacin with fluocinolone acetonide · Topical otic antibiotic + corticosteroid
Pathways
- Major Haemorrhage / Massive Transfusion · BCSH; RCOA; RCEM; RCS — BCSH Guidelines
- Anaemia Investigation · BSH / NICE
- Splenomegaly Workup · BSH; BMJ Best Practice
- Deep Vein Thrombosis Diagnosis and Treatment · NICE CG144 / NICE NG158
- Sickle Cell Crisis · BSH 2021 / BCSH
- Neutropenic Sepsis · NICE CG151 2012 / ESMO
Decision support only — verify against MDCalc, NICE, or your local guideline before clinical use.